Home Ovarian cancer Ovacome Christmas Cards 2008 Ovacome Calendar 2009 Resources Real-life stories Newsletters News What you can do About us

Topotecan chemotherapy

Topotecan, otherwise known as Hycamtin, is a new type of chemotherapy that is being used to treat some types of cancer, including ovarian cancer. This factsheet describes topotecan, how it is given and the side effects that it may cause. It is important to know that each person's reaction to chemotherapy is different. Some people experience very few side-effects, while others may experience more.

Please let your doctor or nurse know about any side effects you have, even if they have gone by the time you attend for your next hospital appointment. Treatment can often be prescribed to relieve them. You will have regular appointments with your doctor to monitor the effect of the chemotherapy and side effects.

How it is given

Topotecan is administered via an intravenous infusion or "drip" into a vein through a very small and very thin plastic tube called a cannula. Each infusion lasts about half an hour and will be given to you in the out-patient department. You will be given the tapotecan infusion on five consecutive days, every three weeks. This means you will have one week of chemotherapy, then two weeks off before coming back for your next regimen. You may receive six or more such cycles of treatment if there is evidence of benefit.

Common side effects

Other side effects

After extensive early research the side effects described above have been found to be the most likely to occur. However, topotecan is a new drug that is still being monitored. If you have any unusual symptoms please let your doctor know about them, even if they do not trouble you.


Secondary navigation